GlaxoSmithKline plc (GSK) Stock Research, Analysis & News

Quick Analysis on GlaxoSmithKline plc (GSK.L) Stock as of March 29, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about GlaxoSmithKline plc (GSK.L) Stock below)

GlaxoSmithKline plc (GSK.L) Stock Profile Summary

GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company offers prescription medicines to treat a range of conditions, such as infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets approximately 25 vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company offers OTC medicines, such as alli, a weight loss medicine; Gaviscon, an antacid product; Panadol, a paracetamol-based pain reliever; smoking control products under NiQuitin and Nicorette names; and other brands, including Breathe Right nasal strips and snore relief products. Its oral healthcare products primarily comprise Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; and Sensodyne, a range of toothbrushes, toothpastes, mouthwashes, and dental floss. Further, the company provides nutritional healthcare products, such as Lucozade, a range of energy and sports drinks; Horlicks, a nutritional drink made from wheat, milk, and malted barley; and Ribena, a blackcurrant juice-based drink. Additionally, it offers products for dermatological treatments, pain relief, allergy treatment, cold and flu treatment, gastrointestinal conditions, feminine hygiene, nicotine replacement therapy, and HIV treatment. GlaxoSmithKline operates in the United States, Europe, China, Japan, the Middle East, Africa, Latin America, and Canada. It has a research collaboration with Eyegate Pharmaceuticals, Inc. to evaluate the delivery of the companys therapies to the anterior and posterior tissues of the eye using the EyeGate II delivery system. The company was founded in 1935 and is based in Brentford, the United Kingdom.

GlaxoSmithKline plc (GSK.L) Stock Key Statistics Research and Analysis as of March 29, 2020

Mutual Funds with GlaxoSmithKline plc (GSK.L) Stock in its top 10 holdings

FundCategoryGSK.L Holding Percentage
Berwyn CornerstoneLarge Value2.97%
Buffalo Flexible IncomeAllocation--50% to 70% Equity2.27%
Delaware Healthcare AHealth4.42%

ETFs with GlaxoSmithKline plc (GSK.L) Stock in its top 10 holdings

Latest Market News on GlaxoSmithKline plc (GSK.L)

Click here to find the latest news on GlaxoSmithKline plc (GSK.L)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center